We are a world-class lab with more than 10 years of experience developing bacteriophage-based treatments. We have one mission: to protect the world as one health. It’s the only solution to the global burden of antibiotic resistance generated by its indiscriminate use, which affects millions of lives everyday and everywhere.

In pursuit of this mission, our treatment development is 100% tailored for the efficient control of bacteria in poultry, cattle and aquaculture production systems industry. All of this is possible thanks to our staff and LEIDEN®, our AI platform based in deep epidemiological diagnostics algorithms to create effective results in bacterial population control in record time.

Our production of custom solutions is rising constantly as we land in different locations throughout the globe. Let’s create a safe and sustainable future for all, because science works and we can prove it.


WE SHARE ONE HEALTH. 
 
Visit us at www.phage-lab.com


PhageLab® is registered as a trademark in Chile, Brazil, Peru, Mexico, Europe and United Kingdom.

Leiden® is registered as a trademark in Chile, Brazil, Peru, Mexico and Thailand.

Copyright © 2010 - 2023, PhageLab Chile SpA or its affiliates. All rights reserved for its own use.

PhageLab

You may have heard that we developed one of the latest products that joined the portfolio of MSD Salud Animal and we wanted to tell you more about it.

#PHAGEIN is a powder solution, based on selected bacteriophages, that improves intestinal health in calves by controlling the spread of pathogenic bacteria (E.coli and Salmonella spp) responsible for infectious diarrhea.
This great product also does not interfere with calves' normal gut microbiota!

We also wanted to show you more about it, so we made a video to explain how it works. Follow the link to watch it https://lnkd.in/e8HRKERk.

#ScienceWorks #MSD #AnimalHealth

This week, on February 11, the International Day of Women and Girls in Science is commemorated. To honor this upcoming and important date, we wanted to share the experience with science from an early age of our Research Quality Assurance Head and biochemist, Bárbara Godoy Miranda.
 
Check out her story!

#ScienceWorks #WomenInScience #Biochemestry

The issue of bacterial infections is quite an important one nowadays as it is closely linked to the overuse of antibiotics and therefore to antimicrobial resistance (AMR).

If you want to know more about what they are and alternatives to control them, read the article in our content hub: https://lnkd.in/eqhpPZFm.

#ScienceWorks #BacterialInfections #AntimicrobialResistance

Hans Pieringer is at it again! This time, our CEO was featured on Innovación El Mercurio because of his achievements and his work at our company. The piece is about innovation and the 200 people with whom Chile is facing great global transitions.
We are happy to be a part of this list and to be amongst such inspirational people and their contributions.

#ScienceWorks #Innovation #BiotechCompany

Our CEO, Hans Pieringer will be a guest on today’s Rockstars by TXSPlus, a science-driven broadcast hosted by none other than Gabriel León. They will discuss the global bacterial challenges the world is experiencing and how they are affecting us.
Watch it live today at 12:00 pm, Santiago time: https://lnkd.in/eenEeY3.
If you miss it, don't worry, it will be available later as a podcast.

#ScienceWorks #GlobalBacterialChallenges #Rockstars

It’s been an intense and productive year for us, and we’d love to congratulate and celebrate everybody that was a part of it. That’s why our CTO, Pablo Cifuentes Palma, wanted to leave our team members with some heartfelt and encouraging words about the massive achievements we had this year.

We all know 2023 comes with big challenges, but we are ready to face them and turn them into chances to grow even more, as a company and as a team.

#ScienceWorks #GrowingCompany #GoPhagers

It’s time to welcome our new phagers. From manufacturing to artificial intelligence our teams keep growing.

At PhageLab® we work for something very meaningful and we are sure these guys are fitting right in.

#ScienceWorks #GoPhagers #GrowingCompany

We are a global company consistently looking for talented people to join us in our mission to defend the world against the antibiotic crisis. From #Biotechnology to #DataScience, our teams are constantly growing, and you could be a part of our future.
 
What can we promise you? A cutting-edge lab with a flexible and fun work environment, friendly people, and growth opportunities.

Follow us to learn more and be up to date with our open positions.

#ScienceWorks #Recruitment #JobOpportunities

In the UK, the Members of Parliament (MPs) are examining the use of phages to fight antimicrobial resistance, inquiring into the approach to regulations, research, and funding. All things that may be slowing the development of bacteriophage-based treatments to help prevent this menacing global health issue.

We are very glad to see how this effective alternative to antibiotics is gaining ground and how it is becoming more and more relevant for decision-makers today. 

Read more about it:  https://lnkd.in/eG8-ZngY

#ScienceWorks #Bacteriophages #AntimicrobialResistance

Today World Futures Day is commemorated, an open invitation to all countries to develop capacities to address upcoming challenges and ensure sustainable development for the next generations. 
It is a time to reflect on the opportunities we have, the threats to our planet, and the implementation of initiatives for the future.

Working to protect the world from problems to come, such as the antimicrobial resistance crisis, is paramount to have a safer future. That is why we need science and innovation today.

Follow the link (https://lnkd.in/gBvE8cna) to read more about this proclaimed day by the UNESCO

#ScienceWorks #WorldFuturesDay #AntimicrobialResistance

Euro

CrUX Dataset

Person Schema

Gravatar Profiles

Pound Sterling

CrUX Top 10m

MailChimp for WordPress

CEO and Founder

Hans Pieringer

Chief Technology Officer

Pablo Palma

Head of Legal & Compliance

DAVID Samet

Sales and Support

Alexa Siebert Llorens

Research Associate

Daniel Castillo

Veterinário

Felipe Mamprin

Principal Scientist of Development

Matías Barrios

Head of Research Projects & Phages

Nicolas Cifuentes

Socio Fundador Phage Lab

Nicolas Ferreira

Pablo Cifuentes

Co-founder and CTO

Diego Belmar

Founder & COO

Co-Founder and CEO

Co-Founder and COO

Nico Ferre

Founder

Micro VC Funded Companies (Top 10K)

Consulting Early Stage Companies With Fewer Than 100 Employees

South America Companies With Less Than $1B in Revenue (Top 10K)

South America Biotechnology Companies

Phage Technologies SA was founded in 2009 from three Engineers interested in Biotechnology, University Andrés Bello by applying scientific research and development as a tool for generating solutions to industrial level and thus create value in products national origin, towards domestic consumption and export. This has prompted the creation of a team working believer in the ability of biotechnology, intellectually capable, proactive, innovative and entrepreneurial, who wanted to start finding the necessary solutions to the problems limiting in various industries from a point of view biological.

Series A - PhageLab

Seed Round - PhageLab

Santiago

Region Metropolitana

Chile

South America

Pitch Deck Teardown: PhageLab’s $11M Series A deck

Sample Series A pitch deck: PhageLab's $11M deck

PhageLab raises $11m to treat bacterial outbreaks in livestock

PhageLab Raises $11M in Funding

PhageLab Gains $11M to Bring Bacteriophage Solutions to the Livestock Industry

PhageLab Raises $11 Million to Develop Bacteriophage Solutions to Treat Bacterial Outbreaks in the Livestock Industry

Colombia

Greece

Europe

Argentina

Pakistan

Asia

HTML5

Google Analytics

Wordpress

Google Fonts

Cloudflare CDN

jQuery

Vimeo

Google Tag Manager

PhageLab is a biotechnology company focused on developing bacteriophage-based solutions to combat antibiotic resistance in the livestock industry. The company utilizes AI and a proprietary microbial bioinformatics platform to create customized phage-based treatments for pathogenic bacteria, aiming to reduce antibiotic dependence and improve animal health.

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Oct 30, 2024 1:02 PM	055d057d
crunchbase profile	general	Oct 30, 2024 10:29 PM	75d0f718
li profile	general	Feb 2, 2024 8:21 PM	aa5c5d84
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	dfd2f42a
peers	general	Feb 2, 2024 8:21 PM	014a0522
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:PHAGE-LAB

PhageLab